Medical treatment of chronic sinusitis in obstructive pulmonary diseases

The effect of medical treatment of chronic rhinosinusitis on clinical symptoms and pulmonary function in patients with chronic obstructive pulmonary disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231012059698N1

Enrollment

100

Registered

2025-06-09

Start date

2025-05-24

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention 1: Intervention Group: Apart from the classic and routine treatment for COPD in this group, the patients will be treated for chronic rhinosinusitis with Mometasone (Restanex, Sina Darou)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All chronic obstructive pulmonary disease patients with chronic rhinosinusitis .

Exclusion criteria

Exclusion criteria: Patients with multiple attacks of exacerbation Patients receiving systemic corticosteroids

Design outcomes

Primary

Measure	Time frame
Chronic Obstructive Pulmonary Disease Questionnaire (CAT). Timepoint: Before and two months after the intervention. Method of measurement: Questionnaire (CAT).	—

Secondary

Measure	Time frame
The frequency of COPD attacks. Timepoint: Before and two months after treatment (Intervention). Method of measurement: Attack rate questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Akhondian

Mashhad University of Medical Sciences

akhoundianm911@gmail.com+98 51 3761 5101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026